Rhythm Pharmaceuticals, Inc. Gains 31.48%

Wed, Jul 13, 2022 at 08:33 PM
Rhythm Pharmaceuticals, Inc. Gains 31.48%

Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) soared at $8.77, a gain of 31.5%. On Wed, Jul 13, 2022, RYTM:NASDAQ touched a New 2-Week High of $8.77. The stock appeared on our News Catalysts scanner on Wed, Jul 13, 2022 at 02:39 PM in the 'MISCELLANEOUS' category. From Wed, Jun 29, 2022, the stock recorded 77.78% Up Days and 70.00% Green Days

About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.